Skip to main content
HairCited

Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination.

Hsiang-Chiun Teng, Hsin-Hsu Chen
Case Report Clinical case reports 2023 8 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37192849'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Case Reports
Population
None
Dauer
4 weeks
Intervention
Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination. None
Vergleichsgruppe
None
Primärer Endpunkt
hair growth/density
Wirkungsrichtung
Neutral
Verzerrungsrisiko
High

Abstract

KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID-19 vaccination. Platelet-rich plasma (PRP) has an outstanding anti-inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34-year-old female with no systemic illness presented with non-scarring hair loss after the second COVID-19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double-spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.

Zusammenfassung

Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids.

Used In Evidence Reviews

Similar Papers